Jennifer Bendiske

809 total citations
12 papers, 635 citations indexed

About

Jennifer Bendiske is a scholar working on Cellular and Molecular Neuroscience, Physiology and Cell Biology. According to data from OpenAlex, Jennifer Bendiske has authored 12 papers receiving a total of 635 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Cellular and Molecular Neuroscience, 4 papers in Physiology and 3 papers in Cell Biology. Recurrent topics in Jennifer Bendiske's work include Neuroscience and Neuropharmacology Research (5 papers), Alzheimer's disease research and treatments (4 papers) and Hearing, Cochlea, Tinnitus, Genetics (2 papers). Jennifer Bendiske is often cited by papers focused on Neuroscience and Neuropharmacology Research (5 papers), Alzheimer's disease research and treatments (4 papers) and Hearing, Cochlea, Tinnitus, Genetics (2 papers). Jennifer Bendiske collaborates with scholars based in United States, France and Switzerland. Jennifer Bendiske's co-authors include Ben A. Bahr, Queenie B. Brown, David Butler, David A. Karanian, Mary L. Michaelis, Jyotirmoy Dey, Johan Baeck, Olatoyosi Odenike, John C. Byrd and Ian W. Flinn and has published in prestigious journals such as Journal of Clinical Oncology, Blood and Journal of Neurochemistry.

In The Last Decade

Jennifer Bendiske

12 papers receiving 620 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Jennifer Bendiske United States 11 258 213 156 125 89 12 635
Andrés Norambuena United States 16 257 1.0× 477 2.2× 179 1.1× 125 1.0× 60 0.7× 24 758
April M. Weissmiller United States 16 213 0.8× 584 2.7× 131 0.8× 174 1.4× 91 1.0× 30 926
Mikiro Nawa Japan 15 330 1.3× 363 1.7× 50 0.3× 155 1.2× 32 0.4× 23 714
María A. Morán Spain 10 176 0.7× 498 2.3× 142 0.9× 309 2.5× 36 0.4× 11 691
Chhavy Tep United States 11 140 0.5× 406 1.9× 116 0.7× 358 2.9× 42 0.5× 14 782
Dae-Hoon Lee South Korea 8 144 0.6× 291 1.4× 157 1.0× 68 0.5× 31 0.3× 9 474
John J. McMahon United States 12 124 0.5× 567 2.7× 111 0.7× 224 1.8× 65 0.7× 14 874
Elisa Matas-Rico Netherlands 12 110 0.4× 559 2.6× 177 1.1× 74 0.6× 57 0.6× 19 744
Michael Kurnellas United States 16 190 0.7× 473 2.2× 85 0.5× 157 1.3× 36 0.4× 30 819

Countries citing papers authored by Jennifer Bendiske

Since Specialization
Citations

This map shows the geographic impact of Jennifer Bendiske's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jennifer Bendiske with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jennifer Bendiske more than expected).

Fields of papers citing papers by Jennifer Bendiske

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jennifer Bendiske. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jennifer Bendiske. The network helps show where Jennifer Bendiske may publish in the future.

Co-authorship network of co-authors of Jennifer Bendiske

This figure shows the co-authorship network connecting the top 25 collaborators of Jennifer Bendiske. A scholar is included among the top collaborators of Jennifer Bendiske based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jennifer Bendiske. Jennifer Bendiske is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

12 of 12 papers shown
1.
Chiappori, Alberto, Charles C. Williams, Ben Creelan, et al.. (2018). Phase I/II study of the A2AR antagonist NIR178 (PBF-509), an oral immunotherapy, in patients (pts) with advanced NSCLC.. Journal of Clinical Oncology. 36(15_suppl). 9089–9089. 37 indexed citations
2.
Hyman, David M., Ben Tran, Jesús Corral Jaime, et al.. (2016). Phase Ib study of BGJ398 in combination with BYL719 in patients (pts) with select advanced solid tumors.. Journal of Clinical Oncology. 34(15_suppl). 2500–2500. 14 indexed citations
3.
Byrd, John C., Thomas J. Kipps, Ian W. Flinn, et al.. (2012). Phase I study of the anti-CD40 humanized monoclonal antibody lucatumumab (HCD122) in relapsed chronic lymphocytic leukemia. Leukemia & lymphoma. 53(11). 2136–2142. 90 indexed citations
4.
Bendiske, Jennifer, et al.. (2011). Degeneration in the ventral cochlear nucleus after severe noise damage in mice. Journal of Neuroscience Research. 90(4). 831–841. 18 indexed citations
5.
Freedman, Arnold S., John Kuruvilla, Sarit Assouline, et al.. (2010). Clinical Activity of Lucatumumab (HCD122) In Patients (pts) with Relapsed/Refractory Hodgkin or Non-Hodgkin Lymphoma Treated In a Phase Ia/II Clinical Trial (NCT00670592). Blood. 116(21). 284–284. 11 indexed citations
6.
Bendiske, Jennifer, et al.. (2009). Postnatal development of NT3 and TrkC in mouse ventral cochlear nucleus. Journal of Neuroscience Research. 88(1). 86–94. 7 indexed citations
7.
Butler, David, Jennifer Bendiske, Mary L. Michaelis, David A. Karanian, & Ben A. Bahr. (2007). Microtubule-stabilizing agent prevents protein accumulation-induced loss of synaptic markers. European Journal of Pharmacology. 562(1-2). 20–27. 52 indexed citations
8.
Kanju, Patrick, Kodeeswaran Parameshwaran, Thirumalini Vaithianathan, et al.. (2007). Lysosomal Dysfunction Produces Distinct Alterations in Synaptic α-Amino-3-Hydroxy-5-Methylisoxazolepropionic Acid and N-Methyl-D-Aspartate Receptor Currents in Hippocampus. Journal of Neuropathology & Experimental Neurology. 66(9). 779–788. 17 indexed citations
9.
Bendiske, Jennifer & Ben A. Bahr. (2003). Lysosomal Activation Is a Compensatory Response Against Protein Accumulation and Associated Synaptopathogenesis—An Approach for Slowing Alzheimer Disease?. Journal of Neuropathology & Experimental Neurology. 62(5). 451–463. 119 indexed citations
10.
Bendiske, Jennifer, et al.. (2002). Intracellular Deposition, Microtubule Destabilization, and Transport Failure: An “Early” Pathogenic Cascade Leading to Synaptic Decline. Journal of Neuropathology & Experimental Neurology. 61(7). 640–650. 52 indexed citations
11.
Bahr, Ben A. & Jennifer Bendiske. (2002). The neuropathogenic contributions of lysosomal dysfunction. Journal of Neurochemistry. 83(3). 481–489. 152 indexed citations
12.
Bahr, Ben A., Jennifer Bendiske, Queenie B. Brown, et al.. (2002). Survival Signaling and Selective Neuroprotection Through Glutamatergic Transmission. Experimental Neurology. 174(1). 37–47. 66 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Andrés Norambuena Breakdown of academic impact, for papers by April M. Weissmiller Breakdown of academic impact, for papers by Mikiro Nawa Breakdown of academic impact, for papers by María A. Morán Breakdown of academic impact, for papers by Chhavy Tep Breakdown of academic impact, for papers by Dae-Hoon Lee Breakdown of academic impact, for papers by John J. McMahon Breakdown of academic impact, for papers by Elisa Matas-Rico Breakdown of academic impact, for papers by Michael Kurnellas
Rankless by CCL
2026